Khoramgah Maryam Sadat, Ghanbarian Hossein, Ranjbari Javad, Ebrahimi Nilufar, Tabatabaei Mirakabad Fatemeh Sadat, Ahmady Roozbahany Navid, Abbaszadeh Hojjat Allah, Hosseinzadeh Simzar
Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Bioimpacts. 2023;13(1):31-42. doi: 10.34172/bi.2021.23711. Epub 2021 Dec 15.
Treatment of critical-sized bone defects is challenging. Tissue engineering as a state-of-the-art method has been concerned with treating these non-self-healing bone defects. Here, we studied the potentials of new three-dimensional nanofibrous scaffolds (3DNS) with and without human adipose mesenchymal stem cells (ADSCs) for reconstructing rat critical-sized calvarial defects (CSCD). Scaffolds were made from 1- polytetrafluoroethylene (PTFE), and polyvinyl alcohol (PVA) (PTFE/ PVA group), and 2- PTFE, PVA, and graphene oxide (GO) nanoparticle (PTFE/ PVA/GO group) and seeded by ADSCs and incubated in osteogenic media (OM). The expression of key osteogenic proteins including Runt-related transcription factor 2 (Runx2), collagen type Iα (COL Iα), osteocalcin (OCN), and osteonectin (ON) at days 14 and 21 of culture were evaluated by western blot and immunocytochemistry methods. Next, 40 selected rats were assigned to five groups (n=8) to create CSCD which will be filled by scaffolds or cell-containing scaffolds. The groups were denominated as the following order: Control (empty defects), PTFE/PVA (PTFE/PVA scaffolds implant), PTFE/PVA/GO (PTFE/PVA/GO scaffolds implant), PTFE/PVA/Cell group (PTFE/PVA scaffolds containing ADSCs implant), and PTFE/PVA/GO/Cell group (PTFE/PVA/GO scaffolds containing ADSCs implant). Six and 12 weeks after implantation, the animals were sacrificed and bone regeneration was evaluated using computerized tomography (CT), and hematoxylin-eosin (H&E) staining. Based on the in-vitro study, expression of bone-related proteins in ADSCs seeded on PTFE/PVA/GO scaffolds were significantly higher than PTFE/PVA scaffolds and TCPS (<0.05). Based on the in-vivo study, bone regeneration in CSCD were filled with PTFE/PVA/GO scaffolds containing ADSCs were significantly higher than PTFE/PVA scaffolds containing ADSCs (<0.05). CSCD filled with cell-seeded scaffolds showed higher bone regeneration in comparison with CSCD filled with scaffolds only (<0.05). The data provided evidence showing new freeze-dried nanofibrous scaffolds formed from hydrophobic (PTFE) and hydrophilic (PVA) polymers with and without GO provide a suitable environment for ADSCs due to the expression of bone-related proteins. ADSCs and GO in the implanted scaffolds had a distinct effect on the bone regeneration process in this in-vivo study.
治疗临界尺寸的骨缺损具有挑战性。组织工程作为一种先进的方法,一直致力于治疗这些无法自愈的骨缺损。在此,我们研究了含和不含人脂肪间充质干细胞(ADSCs)的新型三维纳米纤维支架(3DNS)修复大鼠临界尺寸颅骨缺损(CSCD)的潜力。支架由1-聚四氟乙烯(PTFE)和聚乙烯醇(PVA)制成(PTFE/PVA组),以及2-PTFE、PVA和氧化石墨烯(GO)纳米颗粒(PTFE/PVA/GO组),接种ADSCs并在成骨培养基(OM)中培养。通过蛋白质免疫印迹和免疫细胞化学方法评估培养第14天和21天时关键成骨蛋白包括 runt相关转录因子2(Runx2)、Iα型胶原蛋白(COL Iα)、骨钙素(OCN)和骨连接蛋白(ON)的表达。接下来,将40只选定的大鼠分为五组(n = 8)以制造CSCD,并用支架或含细胞的支架填充。各组按以下顺序命名:对照组(空白缺损)、PTFE/PVA组(植入PTFE/PVA支架)、PTFE/PVA/GO组(植入PTFE/PVA/GO支架)、PTFE/PVA/细胞组(植入含ADSCs的PTFE/PVA支架)和PTFE/PVA/GO/细胞组(植入含ADSCs的PTFE/PVA/GO支架)。植入后6周和12周,处死动物并使用计算机断层扫描(CT)和苏木精-伊红(H&E)染色评估骨再生情况。基于体外研究,接种在PTFE/PVA/GO支架上的ADSCs中骨相关蛋白的表达明显高于PTFE/PVA支架和组织培养聚苯乙烯(TCPS)(<0.05)。基于体内研究,用含ADSCs的PTFE/PVA/GO支架填充的CSCD中的骨再生明显高于含ADSCs的PTFE/PVA支架(<0.05)。与仅用支架填充的CSCD相比,用含细胞支架填充的CSCD显示出更高的骨再生(<0.05)。数据提供了证据表明,由疏水(PTFE)和亲水(PVA)聚合物制成的含和不含GO的新型冻干纳米纤维支架,由于骨相关蛋白的表达,为ADSCs提供了合适的环境。在这项体内研究中,植入支架中的ADSCs和GO对骨再生过程有显著影响。